About FDA

CDER Office of Drug Evaluation II Organization Chart

 

Food and Drug Administration
Office of Medical Products and Tobacco
Center for Drug Evaluation and Research
Office of New Drugs
Office of Drug Evaluation II

 

Leadership

Office NameDirector TitleDirectorDeputy Director TitleDeputy DirectorEmployee 3 TitleEmployee 3Employee 4 TitleEmployee 4Employee 5 TitleEmployee 5Employee 6 TitleEmployee 6Employee 7 TitleEmployee 7Employee 8 TitleEmployee 8Employee 9 TitleEmployee 9Employee 10 TitleEmployee 10Employee 11 TitleEmployee 11Employee 12 TitleEmployee 12Employee 13 TitleEmployee 13Employee 14 TitleEmployee 14Employee 15 TitleEmployee 15SAC
Office of Drug Evaluation IIDirectorVacantDeputy DirectorMary Thanh Hai, M.D.                          (DKKNRB)

Offices

Office NameDirector TitleDirectorDeputy Director TitleDeputy DirectorEmployee 3 TitleEmployee 3Employee 4 TitleEmployee 4Reports ToSAC
           
           
           
           
           
           
           

 

IMPORTANT: The offices table above is limited to a maximum 7 offices. Do not add an additional row for more than 7 offices.


Main Tel: 301-796-2310 | Fax: 301-796-9717 | White Oak Building 22, Room 3214, 10903 New Hampshire Ave., Silver Spring, MD 20993

Approved by FDA Reorganization Coordinator and Principal Delegation Control Officer

Return to Center for Drug Evaluation and Research Organization Charts

Page Last Updated: 09/13/2018
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English